“Hepatocellular carcinoma: A life-threatening disease”-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

“Hepatocellular carcinoma: A life-threatening disease”

Published:2016-12 Issue: Volume:84 Page:1679-1688
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Chacko Shinu,Samanta Subir

Funder

University Grants Commission, New Delhi

Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference53 articles.

1. Modern Pharmacology with Clinical Applications;Craig,2004

2. Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012;Globocan,2012

3. Enhancing the efficacy of hepatocellular carcinoma chemotherapeutics with natural anticancer agents;Alisi;Nutr. Rev.,2007

4. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis;Velázquez;Hepatology,2003

5. Epidemiology of hepatocellular carcinoma in India;Acharya;J. Clin. Exp. Hepatol.,2014

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sesquilignans PD from Zanthoxylum nitidum var. tomentosum exerts antitumor effects via the ROS/MAPK pathway in liver cancer cells;Journal of Asian Natural Products Research;2024-07-03

2. Hepatitis B-related hepatocellular carcinoma: classification and prognostic model based on programmed cell death genes;Frontiers in Immunology;2024-05-10

3. Apigenin Suppresses MED28-Mediated Cell Growth in Human Liver Cancer Cells;Journal of Agricultural and Food Chemistry;2024-04-15

4. Case Report and Literature Review of Multi-drugs Synergy and Targeted Comprehensive Treatment in Advanced Hepatocellular Carcinoma;Current Cancer Drug Targets;2024-03

5. Silencing of KIF2C enhances the sensitivity of hepatocellular carcinoma cells to cisplatin through regulating the PI3K/AKT/MAPK signaling pathway;Anti-Cancer Drugs;2023-12-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3